Polyporus

Many names, one species

Zhu Ling (China, 猪苓 - "pig mushroom", from the resemblance of the sclerotium to a piece of pig skin), chorei (Japan), umbrella polypore or lumpy bracket (English - from the shape of the above-ground fruiting body), żagiew wielogłowa (Poland, the official botanical name), żagwica wielogłowa, chropiatka wielogłowa, huba okółkowa (regionally). All these names refer to the same species: Polyporus umbellatus (synonym Grifola umbellata). In Poland żagiew wielogłowa is a rare species, under STRICT protection since 2014 (previously also protected) - the strictest protective status of all the mushrooms in the Aloha Fungi portfolio. Practical consequence: wild Polyporus from Polish forests is NOT PERMITTED for supplementation. All raw material on the European market comes from controlled cultivation in China and some European countries. The first written mention of Zhu Ling comes from Shen Nong Ben Cao Jing (The Divine Farmer's Materia Medica Classic), dated to the Han dynasty period (2nd century BCE - 2nd century CE), where it was classified in the category of "water-draining" mushrooms. It is a classic ingredient of two traditional TCM formulas: Zhu Ling Tang (Polyporus Decoction, described in Zhang Zhongjing's "Shang Han Lun", ca. 220 CE) and Wu Ling San (Five-Ingredient Powder with Hoelen).

Typical batch specification

Typical batch: β-glucans above 30% by Megazyme K-YBGL method (EUROFINS laboratory). PPS (polysaccharide-peptide, 30-100 kDa) [TBD: typical value]% by chromatographic fractionation with SEC-MALS verification. Total polyporusterones [TBD: typical value]% by HPLC. Ergon [TBD: typical value] mg/g by HPLC. Extraction ratio 10:1. Moisture ≤ 5%. Microbiology compliant with the European Pharmacopoeia (Ph.Eur.). Every batch comes with a full COA including test methodology. For partners requiring the highest precision, we offer DNA barcoding species verification (ITS1/ITS2) (Polyporus is confused with other Polyporus species with significantly different bioactive profiles).

Premium variant

★ Co-branding

For brands that want to create their own functional-mushroom product and base it on our raw-material standard. You use extracts selected by Aloha Fungi, and once the criteria are met you can add our quality seal to your packaging.

MOQ: 5 kg

Our logo on your product →

Mechanisms described in the literature

The mechanisms of action of Polyporus umbellatus are, in a nephrological sense, better described than for most functional mushrooms, owing to the registration of PPS as an adjuvant drug in China. Three main lines of evidence.

1. 01

   Diuresis via aquaporins and the renin-angiotensin-aldosterone system

   The best-described and most characteristic mechanism of Polyporus. Water extract of the sclerotium increases diuresis in animals and humans, but unlike pharmacological loop diuretics (furosemide) or thiazide diuretics (hydrochlorothiazide) it does not cause hypokalaemia or significant sodium loss. The mechanism is twofold: ergon exhibits anti-aldosterone activity (inhibiting sodium reabsorption in the distal tubules) [Yuan 2004]; polyporusterones and the aqueous fraction modify the expression of aquaporins AQP1, AQP2 and AQP3 in the renal medulla and the activity of the vasopressin V2 receptor [Zhang G et al. 2010, J Ethnopharmacol]. The Zhang 2010 study in Wistar rats showed that oral administration of the aqueous extract increases urine production without the loss of potassium and sodium typical of loop diuretics. Clinically: the diuresis is milder and more physiological than with pharmacological diuretics.

2. 02

   Immunomodulation via PPS and TLR4 activation

   The second most important mechanism. PPS (Polyporus Polysaccharide) binds as an agonist to the TLR4 receptor on dendritic cells and macrophages [Li X et al. 2010, Cell Immunol 265(1):50-56; Li X & Xu W 2011, J Ethnopharmacol 135(1):1-6]. This activates NF-κB and MyD88 cytokine cascades, leading to polarisation of macrophages towards the M1 phenotype (pro-inflammatory, "attacking") and increased production of IL-1β, TNF-α, iNOS. PPS additionally activates the T-helper 1 response and NK cells. The mechanism is significantly different from the β-glucans of Reishi and Chaga (which act via Dectin-1), which is an argument for complementary combination. In China injectable PPS is registered as an adjuvant drug in chronic viral hepatitis B and in therapy of urinary-bladder cancer recurrence (as support after BCG therapy) [Zhang 2015]. This is analogous to PSK / krestin in Japan for Coriolus - the regulatory difference: injectable PPS is a DRUG in China, our oral extract is a food SUPPLEMENT in the EU.

3. 03

   Nephroprotection in preclinical models

   The third mechanism. Polyporus shows a protective effect on the nephron in animal models of nephrotoxicity (ischaemia, nephrotoxic drugs), likely through modulation of inflammatory cytokines and oxidative stress in the renal tubules. In Italy, therapeutic mycology (the Stamets-Brigatti school) uses Polyporus as support in post-operative lymphoedema (especially after mastectomy), in lower-limb oedema and in mild premenstrual water retention - all observations are open clinical series; large RCTs are lacking. All observations require confirmation in larger clinical RCTs in humans.

• LONGEVITY

  Polyporus kapsulki 90 szt.

  Kapsulki 90 szt.

  Linia Limfa - codzienny przeplyw i drenaz limfatyczny w formie kapsulkowej.

  129,00 złShop →

Extract applications

Polyporus is a specialist mushroom with a stronger pharmacological profile than most mushrooms in the portfolio, so its applications are narrower than for Reishi/Lion's Mane/Shiitake. Capsules - typically 300-500 mg extract per capsule (typical protocols 500-2000 mg/day, cycles of 4-8 weeks). Powder, in classic TCM formulas (Zhu Ling Tang, Wu Ling San - multi-component compositions), in infusions with other diuretic herbs (nettle, birch, couch grass). Polyporus has a sweetish-bland, slightly bitter, non-invasive flavour. Liquid extract (tincture), drops under the tongue for 30-60 seconds or into a drink. Chocolates and bars - Polyporus is rarely used in culinary products owing to its pharmacological profile (it is not a "food medicine" like Shiitake). "Lymph support", "edema relief", "kidney detox" supplements - typical positioning in the Western industry. NOTE: these claims in the EU require EFSA authorisation - section H. Polyporus is a mushroom of SHORT COURSES (4-8 weeks, cycles 2-3 times per year), not multi-year daily supplementation - this distinguishes it from Reishi/Lion's Mane/Shiitake.

Precautions

Polyporus belongs to mushrooms with a STRONGER pharmacological profile than most functional mushrooms, so the list of precautions is longer. Safety in classical TCM use (short courses, low doses in formulas with other herbs) is good, but standalone use of a concentrated extract requires particular attention.

Absolute contraindications: pregnancy and breastfeeding (classical TCM advises against Polyporus in pregnancy due to strong draining action; lack of adequate RCTs). Renal insufficiency stage 3 and above (eGFR below 60 ml/min/1.73 m²) - Polyporus increases the filtration load on the nephron. Active heart failure with oedema requiring pharmacological treatment - Polyporus as a mild diuretic does not replace treatment for this patient group and may cloud the clinical picture. Children under 18 years of age (no safety studies). Known allergy to mushrooms of the Polyporaceae family. Post organ-transplant status with active immunosuppression - PPS activates TLR4 and innate immunity.

Consultation with a doctor required: antihypertensive drugs and diuretics (ACE inhibitors, sartans, beta blockers, thiazides, furosemide) - Polyporus is additive with pharmacological diuretics, which may lead to excessive diuresis, orthostatic hypotension and electrolyte disturbances. Blood-pressure and electrolyte monitoring, possible adjustment of drug dose by the attending physician. Anticoagulants and antiplatelet drugs (warfarin, NOACs, clopidogrel, ASA) - polysaccharides may mildly affect platelet aggregation. INR monitoring with warfarin. Chemotherapy and radiotherapy in progress - in China injectable PPS is used as an adjuvant, but oral Polyporus extract outside China requires consultation with the attending oncologist. Antidiabetic drugs - isolated studies describe a mild hypoglycaemic effect. Autoimmune diseases in remission - TLR4 activation may affect immunological activity. Predisposition to nephrolithiasis with a specific stone type (oxalate, struvite) - Polyporus increases diuresis (physiologically reducing the risk of stones), but requires concurrent good hydration (1.5-2 L of water daily). Planned surgeries - discontinue 14 days before the procedure.

Possible adverse effects: excessive diuresis and nocturia (passing urine at night) at too high a dose or with evening intake - which is why Polyporus is always taken in the morning or before noon, never in the evening. Orthostatic hypotension (dizziness on standing) when combined with antihypertensives without supervision. Mild electrolyte disturbances (rare, mainly with long-term use at high doses or in combination with loop diuretics) - which is why Polyporus is a mushroom of SHORT COURSES. As standard we include the key warnings on the consumer label of the final product, providing brands with specific wording compliant with EU food law.